Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 15, 2020 08:52AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
narmac, and not to mention the misinformation on both ticker symbols, ZHCLF & ZENI.P, on the internet. They got you coming and going.
According to josh4580 (he), he picked up ZCC (Zenith Epigenetics as we know it) stock. Who's to stay that isn't so?
Koo